New PET dye fails to prove superior in lymphoma staging trial
NCT ID NCT06125028
First seen Nov 01, 2025 · Last updated Apr 30, 2026 · Updated 24 times
Summary
This study tested a new imaging agent called [68Ga]Ga-PentixaFor against the standard FDG PET scan to see which one better detects tumors in people with marginal zone lymphoma. Only 8 people enrolled before the trial was stopped early. The goal was to improve cancer staging, but the study did not reach its full planned size.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MARGINAL ZONE LYMPHOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CHU La Timone
Marseille, 13005, France
-
CHU de Bordeaux
Bordeaux, 33600, France
-
CHU de Nantes
Nantes, 44093, France
-
Clinica Universidad de Navarra
Pamplona, Navarre, 31008, Spain
-
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Rome, 00168, Italy
-
Hôpital Cochin
Paris, 75014, France
-
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Bologna, 40138, Italy
-
L'IRCCS Istituto Romagnolo per lo Studio dei Tumori "Dino Amadori" - IRST S.r.l
Meldola, 47014, Italy
-
Medizinische Universität Innsbruck
Innsbruck, 6020, Austria
-
Ospedale San Raffaele S.r.l.
Milan, 20132, Italy
-
Universitätsklinikum Essen
Essen, 45147, Germany
-
Universitätsklinikum Würzburg
Würzburg, 97080, Germany
Conditions
Explore the condition pages connected to this study.